Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing Cancers

Clinical trial NCT05099549 · TERMINATED

Trial details

NCT number: NCT05099549
Sponsor: NKGen Biotech, Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Squamous Cell Carcinoma of Head and Neck Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Advanced Solid Tumor Refractory Tumor Metastatic Tumor

Start date: 2021-11-03
Primary completion: 2023-09-21
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.